A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle.
about
Sex hormones selectively impact the endocervical mucosal microenvironment: implications for HIV transmissionHormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysisBeyond the Pap Smear: Gender-responsive HIV Care for WomenBlocking HIV-1 transmission in the female reproductive tract: from microbicide development to exploring local antiviral responsesAnimal and human mucosal tissue models to study HIV biomedical interventions: can we predict success?Challenges in mucosal HIV vaccine development: lessons from non-human primate modelsHSV-2-driven increase in the expression of α4β7 correlates with increased susceptibility to vaginal SHIV(SF162P3) infectionVaginal challenge with an SIV-based dual reporter system reveals that infection can occur throughout the upper and lower female reproductive tractEndocrine control of mucosal immunity in the female reproductive tract: impact of environmental disruptorsWomen and HIV in Sub-Saharan Africa.Personalized Biobehavioral HIV Prevention for Women and Adolescent Girls.Progestin-Containing Contraceptives Alter Expression of Host Defense-Related Genes of the Endometrium and CervixClinical parameters essential to methodology and interpretation of mucosal responsesNew approaches to making the microenvironment of the female reproductive tract hostile to HIV.Greentree white paper: sexual violence, genitoanal injury, and HIV: priorities for research, policy, and practice.Caveats associated with the use of human cervical tissue for HIV and microbicide research.Targeting Trojan Horse leukocytes for HIV prevention.Depo-provera treatment does not abrogate protection from intravenous SIV challenge in female macaques immunized with an attenuated AIDS virus.Setting of methods for analysis of mucosal antibodies in seminal and vaginal fluids of HIV seropositive subjects from Cambodian and Italian cohorts.Friend or Foe: Innate Sensing of HIV in the Female Reproductive Tract.Humoral immune responses to HIV in the mucosal secretions and sera of HIV-infected women.Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodiesEstradiol regulation of constitutive and keratinocyte growth factor-induced CCL20 and CXCL1 secretion by mouse uterine epithelial cells.Uterine epithelial cell regulation of DC-SIGN expression inhibits transmitted/founder HIV-1 trans infection by immature dendritic cellsSex hormones regulate tenofovir-diphosphate in female reproductive tract cells in culture.The role of sex hormones and the tissue environment in immune protection against HIV in the female reproductive tract.Detection of intraepithelial and stromal Langerin and CCR5 positive cells in the human endometrium: potential targets for HIV infection.In situ distribution of HIV-binding CCR5 and C-type lectin receptors in the human endocervical mucosa.Hormonal contraception and HIV acquisition: reanalysis using marginal structural modelingProductive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle.SHIV susceptibility changes during the menstrual cycle of pigtail macaques.Selective impact of HIV disease progression on the innate immune system in the human female reproductive tract.Searching for lower female genital tract soluble and cellular biomarkers: defining levels and predictors in a cohort of healthy Caucasian women.How can we design better vaccines to prevent HIV infection in women?Implications of HIV PrEP trials results.Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract.Prevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen.Effects of tenofovir on cytokines and nucleotidases in HIV-1 target cells and the mucosal tissue environment in the female reproductive tract.Estradiol reduces susceptibility of CD4+ T cells and macrophages to HIV-infection.Immune responses to HIV in the female reproductive tract, immunologic parallels with the gastrointestinal tract, and research implications
P2860
Q21090622-ABFF62D3-61C6-4B32-929D-1B250060F30AQ21144588-174F93D5-E700-431C-9724-4637587CEBB8Q26746179-184963F8-96CB-4A85-88B6-72221ACB3876Q26774878-0034ED20-07F9-4611-86C7-4DFEC8D2C96EQ26777022-68828B50-6E2F-4854-8C1B-FCB56AE80E72Q27022152-0786C2B6-C30F-4F8E-B7F0-41D47AA45903Q27322178-F0039301-09CE-433C-94AF-D776727DFCCBQ27323310-456C513E-2DE6-4B88-9A9D-71639574FF7BQ28388054-75E8241E-A7E9-47D7-B13E-45EEF6332B3DQ30356708-7E63FE04-BE29-415E-8756-299E36CF52C7Q30357818-51DFBCC7-3700-4866-B957-05FDEBA82258Q30358037-AFA7BEE7-0096-48BF-96F1-1843539024D9Q30398452-6B04DA73-547C-4A7C-A332-A10BE1E59D7AQ30398454-0688D024-BCEE-476C-BD93-38F037505A06Q30416473-FD4369AA-D61F-4734-80DE-2C98B951BF40Q33515006-2AB2FE37-73EC-4E56-9FA3-A4AB61F23CBFQ33518390-3640BDA6-6758-4D56-94E4-C3AE9856A5CAQ33547467-D9691A4D-DC84-4FEE-B637-7B711F52EE4CQ33548718-D5E3EC42-C6E5-4A11-B659-A828DE26F469Q33613121-2D8ADF2B-7A42-4F0D-B13B-875D60C85321Q33624872-4AC8FF08-525D-49D5-9E5E-D7BCF7BFE6CCQ33627673-249FFF95-788C-4FAB-BBB3-08A725B948F7Q33748030-9DE11579-5DEE-4D16-B34F-54AA3EF257D8Q33778508-022E2F47-F728-4DD9-8579-D6B0C48675FAQ33825769-ACEFFB44-D2A3-40C0-8831-39212B795ED0Q33934044-384C24F1-C7FA-4266-A59A-1C3A07622C39Q33954795-B200BAED-8296-4B05-82C2-7F1F80C9D982Q34044944-360394C5-B110-4F47-AA0F-8070836B8094Q34123283-1F820CBB-E93E-4D85-8E18-301B44CFE9F5Q34127684-75D96260-F6F8-4952-8785-8BE7FAD9D855Q34243579-4F42A4DF-133B-4221-AF1C-139D150A4678Q34295695-7DDE20BC-97D6-4E47-8967-B6E622825D1FQ34405887-122A96A6-AC39-414D-B168-0356F1088E4FQ34449068-FC3B3E49-E7A0-4FCC-BF1A-698A56BDF66EQ34460987-E8C91B46-112F-480A-9352-3C88CCE07F53Q34467932-1B3848FF-0FDD-478A-95DC-1C1B0662E9DFQ34506545-3D562643-C974-46DA-9A80-DED4C855C388Q34596532-6236E545-92E4-4D76-AA2E-A3B4D6FF3674Q34685567-E0A069A6-8AF1-4843-A984-7ABE04E095C1Q34712244-EDAD6E51-210B-4ED5-A8E5-62F2432EC73F
P2860
A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A new strategy to understand h ...... ty during the menstrual cycle.
@en
A new strategy to understand h ...... ty during the menstrual cycle.
@nl
type
label
A new strategy to understand h ...... ty during the menstrual cycle.
@en
A new strategy to understand h ...... ty during the menstrual cycle.
@nl
prefLabel
A new strategy to understand h ...... ty during the menstrual cycle.
@en
A new strategy to understand h ...... ty during the menstrual cycle.
@nl
P2860
P31
P1433
P1476
A new strategy to understand h ...... ty during the menstrual cycle.
@en
P2093
Charles R Wira
John V Fahey
P2860
P304
P356
10.1097/QAD.0B013E3283060EA4
P407
P577
2008-10-01T00:00:00Z